"Suicide CARE" (Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea): An Update
Overview
Authors
Affiliations
Objective: In 2011, "Suicide CARE" (Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea) was originally developed for the early detection of warning signs of suicide completion, since there is a tendency to regard emotional suppression as a virtue of Korean traditional culture. A total of 1.2 million individuals completed the training program of "Suicide CARE" in Korea.
Methods: More sophisticated suicide prevention approaches according to age, sex, and occupation have been proposed, demanding for a more detailed revision of "Suicide CARE." Thus, during the period from August 2019 to February 2020, "Suicide CARE" has been updated to version 2.0. The assessments on domestic gatekeeper training programs for suicide prevention, international gatekeeper training programs for suicide prevention, psychological autopsy interview reports between 2015 and 2018, and the evaluation of feedback from people who completed "Suicide CARE" version 1.6 training were performed.
Results: We describe the revision process of "Suicide CARE," revealing that "Suicide CARE" version 2.0 has been developed using an evidence-based methodology.
Conclusion: It is expected that "Suicide CARE" version 2.0 be positioned as the basic framework for many developing gatekeeper training programs for suicide prevention in Korea in the near future.
Seol J, Lee H, Lee S, Ki S, Cho S, Oh K Psychiatry Investig. 2025; 21(12):1329-1337.
PMID: 39757812 PMC: 11704805. DOI: 10.30773/pi.2024.0231.
Research for association and correlation between stress at workplace and individual mental health.
Lee M, Lee W Front Public Health. 2024; 12:1439542.
PMID: 39651471 PMC: 11621099. DOI: 10.3389/fpubh.2024.1439542.
Effect of community attitudes on suicide mortality in South Korea: a nationwide ecological study.
Hong M, Kim H, Park C, Lee H, Rhee S, Min S Front Psychiatry. 2024; 15:1423609.
PMID: 39351329 PMC: 11439762. DOI: 10.3389/fpsyt.2024.1423609.
Lee Y, Paik J, Lee H Psychiatry Investig. 2024; 21(7):681-690.
PMID: 39089693 PMC: 11298267. DOI: 10.30773/pi.2024.0184.
Qu D, Zhang X, Liu D, Liu B, Chen D, Cai C Trials. 2024; 25(1):335.
PMID: 38773529 PMC: 11110327. DOI: 10.1186/s13063-024-08137-2.